Synthetic Biologics (SYN) Reports 2016 EPS of ($0.29)

Synthetic Biologics (NYSE: SYN) reported 2016 EPS of ($0.29), $0.21 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c